Logo-jnp
J Nephropathol. 2021;10(1): e05. doi: 10.34172/jnp.2021.05

Original Article

Effects of atrovastatin on concentrations of 3-hydroxy-3-methylglutaryl-coenzyme A- reductase (HMG-CoA-R), proprotein convertase subtilisin/kexin type 9 (PCSK9) and sortilin in patients with type 2 diabetes mellitus and pre-diabetics

Ali Nosrati Andevari 1,2 ORCID, Soheila Moein 1,2 * ORCID, Durdi Qujeq 3,4 * ORCID, Zoleikha Moazezi 5 ORCID, Karimollah Hajian Tilaki 6 ORCID

Cited by CrossRef: 1

1- Andevari A, Koolivand M. Mechanisms and Predisposing Conditions for Statin‐Induced New‐Onset Type 2 Diabetes Mellitus: A Paradox Relative to Their Pleiotropic Metabolic Effects. Endocrino Diabet & Metabol. 2026;9(5) [Crossref]
2- Andevari A, Firoozjaee A, Meftah N, Asciabari H, Bahri F, Shahandashti N, Fallah H, Qujeq D. The effects of atorvastatin consumption on blood levels of sortilin, glycemic, and lipid indices in type 2 diabetic patients: A randomized clinical trial. Int J Diabetes Dev Ctries. 2026;46(3):879 [Crossref]
3- Andevari A, Firoozjaee A, Meftah N, Asciabari H, Bahri F, Shahandashti N, Fallah H, Qujeq D. Response to letter to editor—Letter to the Letter: “The effects of atorvastatin consumption on blood levels of sortilin, glycemic, and lipid indices in type 2 diabetic patients: A randomized clinical trial”. Int J Diabetes Dev Ctries. 2026;46(3):889 [Crossref]